QPS Netherlands B.V

Life Science Sweden heads to the Oresund region! ‒ Hello there Michael Linnell

Life Science Sweden’s The Future of Swedish Danish Life Science and New Updates in Drug Formulation & Bioavailability meetings are coming up soon. We asked Mich...

Column: ”We need to exploit the benefits of the regulations“

You don’t need to search long on the Internet to find lists of the most innovative countries with Sweden ranking at the top. Sweden generally offers good condit...

Trump in new push to lower drug prices

U.S. President Donald Trump announced on Sunday that he plans to sign an executive order to lower the cost of prescription drugs to the same levels paid in othe...

Microscopy in Urinalysis: Observe Urine, Detect Abnormalities

Webinar on 18th March 2025, 10 AM - 11 AM CET.

RegSmart Life Science AB

Wusson Accelerator AB

Webinar: Automate your processes

Free ZEISS webinar on January 30th, 2025.

Astra Zeneca faces potential multimillion-dollar fines in China

Astra Zeneca could be forced to pay up up to $8 million in fines for allegedly unpaid import duties in China, as the company seeks to rebuild trust following ea...

Abbvie förvärvar lovande projekt inom psykisk ohälsa

Abbvie köper ett läkemedelsprogram inom mental hälsa i en miljardaffär som ser lite annorlunda än vad som tidigare uppgetts.

Truly Labs AB

Quality solutions for medical device R&D applications

From R&D to the quality assurance of series production in medical device manufacturing.

Webinar: Support Trial Patients Transitioning to the Commercial Space

Register for expert insights on supporting Phase III clinical trial patients post-approval and read our blog on advanced Patient Assistance Programs.

Nytt godkännande för Elektas Gamma Knife i USA

Strålterapibolaget Elekta har fått klartecken av den amerikanska läkemedelsmyndigheten FDA för att använda sitt Gamma Knife-system vid ytterligare en typ av sär...

One last chance to register for the premier metrology event in 2024

ZEISS QUALITY INNOVATION SUMMIT.

Lilly-chefen om nya fetmaläkemedlet – ”Patienterna förtjänar respekt”

Ännu ett hajpat diabetes- och fetmaläkemedel har gjort sin inmarsch i Sverige – med löften om stabil tillgång och tillgänglighet för patienterna. ”Vi ser att de...

Nytt misslyckande för Pfizer inom blodsjukdom

För andra gången på mindre än ett år har Pfizer drabbats av en tung motgång för sin ambition att ta fram ett effektivt läkemedel för sicklecellssjukdom. Denna g...

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Joy at Egetis after positive CHMP opinion – ”The single most important milestone”

Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."

Marie Gårdmark: “What to expect from Trump’s second term?”

One may complain about the complex multinational system in EU, but it gives us some predictability that cannot be easily overturned by different member states p...

ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin

More than 50 distinguished speakers from leading manufacturing companies.

Are you curious about volume imaging for very large samples?

Exciting ZEISS Webinar!

Spermosens rekryterar vetenskaplig chef

Spermosens rekryterar Maria Liljander som ny Chief Scientific Officer. Hon efterträder Kushagr Punyani i början av maj.

Several departures at the top at Nykode

Members of both the management and the board are leaving the Norwegian biotech company Nykode.